We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 593 results
  1. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review

    To evaluate the efficacy and safety of tocilizumab (TCZ) in the treatment of refractory Takayasu arteritis (TAK). Eleven refractory TAK patients...

    Haiyan Li, Zongwen Shuai in Heart and Vessels
    Article Open access 08 November 2021
  2. A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants

    Mobocertinib (TAK-788) is a first-in-class oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that received accelerated approval...

    Michael J. Hanley, Steven Zhang, ... Neeraj Gupta in Investigational New Drugs
    Article Open access 24 May 2024
  3. Assessing the acceptability and feasibility of reactive drug administration for malaria elimination in a Plasmodium vivax predominant setting: a qualitative study in two provinces in Thailand

    Background

    Reactive case detection (RACD) or testing and treatment of close contacts of recent malaria cases, is commonly practiced in settings...

    Kanokwan Suwannarong, Chris Cotter, ... Adam Bennett in BMC Public Health
    Article Open access 13 July 2023
  4. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis

    Objective

    Coronary artery involvement in Takayasu arteritis (TAK) leads to poor prognosis and high mortality. Tocilizumab (TCZ) has been used to...

    Lili Pan, Juan Du, ... Yujie Zhou in Clinical Rheumatology
    Article 06 March 2020
  5. Near-Infrared Spectroscopy measurements are reliable for studying patellar bone hemodynamics and affected by venous occlusion, but not by skin compression

    Purpose

    According to the homeostasis model, patellofemoral pain (PFP) results from disturbed homeostasis due to vascular insufficiency in the anterior...

    Martin J. Ophey, Anne Westerweel, ... Igor J. R. Tak in Journal of Experimental Orthopaedics
    Article Open access 29 November 2023
  6. Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report

    Background

    Unstable hemoglobinopathies are rare inherited disorders of hemoglobin causing a reduction of hemoglobin molecule solubility. This results...

    Cesare Medri, Adriana Méndez, ... Anne Angelillo-Scherrer in Journal of Medical Case Reports
    Article Open access 10 April 2022
  7. Delayed diagnosis of congenital thrombotic thrombocytopenic purpura in a patient with recurrent strokes

    Congenital thrombotic thrombocytopenic purpura (cTTP) is caused by ADAMTS13 mutations and associated with high risk of microvascular thrombosis. A...

    Marina Beltrami-Moreira, Maria T. DeSancho in Journal of Thrombosis and Thrombolysis
    Article 12 January 2022
  8. Diagnosis of Compound Heterozygous Hb Tak/β-Thalassemia and HbD-Punjab/β-Thalassemia by HbA2 Levels on Capillary Electrophoresis

    A misdiagnosis of β-thalassemia carrier in samples with Hb Tak and HbD-Punjab, the β-variants, can be a cause of inappropriate genetic counseling...

    Sitthichai Panyasai, Supachai Sakkhachornphop, Sakorn Pornprasert in Indian Journal of Hematology and Blood Transfusion
    Article 04 April 2017
  9. Prevalence of malarial recurrence and hematological alteration following the initial drug regimen: a retrospective study in Western Thailand

    Background

    The hematological changes following the initial drug regimen has been poorly understood in Thailand. This study was designed to determine...

    Manas Kotepui, Chuchard Punsawad, ... Bhukdee PhunPhuech in BMC Public Health
    Article Open access 15 October 2019
  10. Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis

    Background

    Long-term data pertaining to rituximab as add-on therapy in childhood-onset lupus nephritis (cLN) is scarce.

    Methods

    A retrospective cohort...

    Eugene Yu-hin Chan, Sze-wa Wong, ... Desmond Yat-hin Yap in Pediatric Nephrology
    Article 26 June 2023
  11. Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients

    Background

    Tumor necrosis factor inhibitors (TNFi) have emerged as an efficient therapeutic modality for rheumatoid arthritis (RA). A ratio of...

    Amira Mohamed Khafagi, Doaa Mosad Mosa, ... Eman Abdelrazek Hafez in Egyptian Rheumatology and Rehabilitation
    Article Open access 30 May 2024
  12. Monogenic lupus with homozygous C4A deficiency presenting as bronchiectasis and immune-mediated thrombocytopenia

    Monogenic lupus is a subset of lupus caused by single-gene disorders, integrating the paradoxical combination of autoimmunity and immunodeficiency....

    Asma S. Tak, Jagatshreya Satapathy, ... Narendra K. Bagri in Rheumatology International
    Article 21 July 2021
  13. Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis

    Background

    Programmed death-1 (PD-1) and programmed death- ligand 1 (PD-L1) inhibitors, such as pembrolizumab, nivolumab and atezolizumab, are major...

    Jiandong Zhou, Sharen Lee, ... Qingpeng Zhang in Cardio-Oncology
    Article Open access 17 March 2022
  14. Size Distribution of Fragments by High-power Holmium Laser Lithotripsy in MiniPCNL with Suction

    Purpose of Review

    Data are lacking on distribution of size of fragments created with the laser lithotripsy, stone density, and composition. Dust...

    Naveen K. Reddy, Abhijit P. Patil, ... Mahesh R. Desai in Current Urology Reports
    Article 16 December 2021
  15. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study

    Background

    Bloodstream infections (BSIs) are an emerging cause of significant morbidity and mortality in severe Coronavirus disease 2019 (COVID-19)....

    Naveenraj Palanisamy, Nakka Vihari, ... Sanjeev Misra in BMC Infectious Diseases
    Article Open access 08 September 2021
  16. Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression

    Objective

    To evaluate systematically the efficacy of exergames for balance dysfunction in neurological conditions and to identify factors of...

    Luca Prosperini, Valentina Tomassini, ... Claudio Marcello Solaro in Journal of Neurology
    Article 23 May 2020
  17. Polysaccharide of Alocasia cucullata Exerts Antitumor Effect by Regulating Bcl-2, Caspase-3 and ERK1/2 Expressions during Long-Time Administration

    Objective

    To study the in vitro and in vivo antitumor effects of the polysaccharide of Alocasia cucullata (PAC) and the underlying mechanism.

    ...
    Qi-chun Zhou, Shi-lin **ao, ... Ying-bo Lin in Chinese Journal of Integrative Medicine
    Article 21 June 2023
  18. Monoclonal antibody applications in travel medicine

    For decades, immunoglobulin preparations have been used to prevent or treat infectious diseases. Since only a few years, monoclonal antibody...

    Hanna K. de Jong, Martin P. Grobusch in Tropical Diseases, Travel Medicine and Vaccines
    Article Open access 15 January 2024
  19. Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2

    The COVID-19 pandemic has caused numerous deaths around the world. A growing body of evidence points to the important role of overwhelming...

    Weijian Hang, Chen Chen, ... Dao Wen Wang in Frontiers of Medicine
    Article 21 March 2021
Did you find what you were looking for? Share feedback.